Fixed on ESG

PGIM

In Fixed on ESG, PGIM's rotating lineup of ESG-expert hosts explore the latest topics and trends of ESG investing. We'll provide our take on the investment implications and value opportunities we see in this space and how changes in the market may directly affect our decision making. Subscribe to hear from PGIM thought leaders, as well as industry professionals and some of our clients.

About PodLP

PodLP is the leading podcast app for feature phones. With 10M+ installs in nearly every country, PodLP is available for KaiOS on the KaiStore and JioStore, as well as Cloud Phone and Android. If you're interested in promoting "Fixed on ESG" on PodLP, contact sales@podlp.com.

Screenshots are mockup renders of PodLP for KaiOS. Actual design may vary based on platform, operating system, and app version.

Fixed on ESG

Episodes (43)

Feb 3rd Assessing the Risk of Antimicrobial Resistance
Dec 23, 2025 COP30: Key Takeaways from the Amazon Summit
Nov 20, 2025 Propelling Equitable Access to Medicine

Fixed on ESG

Feb 3, 2026
19¾ minutes
25 MB

Antimicrobial Resistance (AMR) is one of the most urgent health challenges today, making infections harder—and sometimes impossible—to treat. This episode of Fixed on ESG explores what AMR is, why it matters, and its wide-ranging impact on health systems and the global economy. We also highlight the science behind resistance, why innovation in diagnostics, vaccines, and stewardship is critical, and what investors should consider as AMR drives rising healthcare costs, regulatory pressures, and opportunities in new technologies. PGIM's Birgit Lundem Jakobsen, ESG Specialist, hosts this discussion with Amish Acharya, Senior Scientific and Clinical Advisor from...

Fixed on ESG

Assessing the Risk of Antimicrobial Resistance

PGIM

00:00 -17:56